Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A novel disulfidptosis-related immune checkpoint genes signature: forecasting the prognosis of hepatocellular carcinoma

18 Jul 2023

Abstract excerpt

BACKGROUND: HCC is an extremely malignant tumor with a very poor prognosis. In 2023, a brand-new kind of cell death known as disulfidptosis was identified. Although, the prognosis as well as expression of immune checkpoints that are closely connected with it in HCC remain unknown. METHODS: In this work, we identified 49 genes with abnormal expression in liver cancer and normal liver tissue, with 23 of them being...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Immunotherapy and Biomarkers
Share to Ferroptosis and cancer prognosis
Share to Hepatocellular Carcinoma Treatment and Prognosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 37462769
DOI: 10.1007/s00432-023-05076-4

Provenance

PubMed metadata and Literature Corpus relationships.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A novel disulfidptosis-related immune checkpoint genes signature: forecasting the prognosis of hepatocellular carcinomaPMID 37462769Read ↗

A novel disulfidptosis-related lncRNA signature for predicting prognosis and potential targeted therapy in hepatocellular carcinomaSemantic proximity Read ↗

Personalized Therapies in Hepatocellular Carcinoma: Insights from a Disulfidptosis-Related SignatureSemantic proximity Read ↗

Establishment of a prognostic signature for hepatocellular carcinoma using disulfidptosis-related lncRNAsSemantic proximity Read ↗

Machine Learning-Based Disulfidptosis-Related lncRNA Signature Predicts Prognosis, Immune Infiltration and Drug Sensitivity in Hepatocellular CarcinomaSemantic proximity Read ↗

Novel Disulfidptosis-associated Genetic Signatures to Predict Prognosis in Patients with Hepatocellular CarcinomaSemantic proximity Read ↗

Disulfidptosis classification of hepatocellular carcinoma reveals correlation with clinical prognosis and immune profileSemantic proximity Read ↗

Molecular Subtypes Based on Disulfidptosis-related Genes and Tumor Microenvironment Infiltration Characterization in Hepatocellular CarcinomaSemantic proximity Read ↗

Disulfidptosis-related lncRNAs predict prognosis and immune response of Liver hepatocellular carcinomaSemantic proximity Read ↗

Identification and characterization of a novel molecular classification based on disulfidptosis-related genes to predict prognosis and immunotherapy efficacy in hepatocellular carcinomaSemantic proximity Read ↗

Typing and modeling of hepatocellular carcinoma based on disulfidptosis-related amino acid metabolism genes for predicting prognosis and guiding individualized treatmentSemantic proximity Read ↗

Identification and validation of disulfidptosis-related subtypes and the prognostic model in hepatocellular carcinomaSemantic proximity Read ↗

Identification of disulfidptosis-related genes with immune infiltration in hepatocellular carcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.